Stock Information
Soleno Therapeutics Inc (SLNO)
Ticker Symbol: SLNO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,121.01 mil
Piotroski score: 7
PE Ratio: 130.6549
EPS (TTM): 0.1615
Revenue (TTM): $3.20 M
Dividend Yield: N/A%
ROE: 5.9%
Latest News
-
Soleno Therapeutics 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
Fri, May 1, 2026 5:48 PM
-
SLNO 6-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman
Wed, Apr 29, 2026 2:40 PM
-
SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
Wed, Apr 29, 2026 12:42 PM
-
SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
Mon, Apr 27, 2026 7:13 PM
-
Soleno Therapeutics Inc (NASDAQ:SLNO): A Decent Value Play with Strong Health and Explosive Growth Potential
Mon, Apr 27, 2026 11:10 AM
-
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
Sat, Apr 25, 2026 8:36 AM
Key Financials
Financial data not available
